Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months — United States, April 2024
Link
Description
Reports on maternal respiratory syncytial virus (RSV) vaccination and administration of RSV antibody (nirsevimab) to infants. Includes data by location of residence for rural and nonrural areas.
Author(s)
Hilda Razzaghi, Emma Garacci, Katherine E. Kahn, et al.
Citation
MMWR (Morbidity and Mortality Weekly Report), 73(38), 837-843
Date
09/2024
Type
Document
Organization
Centers for Disease Control and Prevention
Tagged as
Infectious diseases · Maternal health and prenatal care · Rural-urban differences · Statistics and data · Vaccination